Swiss Re introduces guidance for underwriters on repurposed longevity drugs

Share!

Reinsurance News - Aug 12, 2025

Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...

Read Full Article

Recommended Articles

There are challenges, but reinsurance conditions remain favourable: Lockton

Posted: Sep 26, 2025

The property reinsurance market continues to soften and is not without its challenges as sellers con...

Aon strengthens commercial risk sales in India with new Regional Heads

Posted: Sep 26, 2025

Aon has announced the appointments of Raghav Arora, Prasanna Kumar, and Preeti D’Silva to its...

Ardian becomes lead shareholder in Diot-Siaci

Posted: Sep 26, 2025

The Diot-Siaci Group, a specialist insurance and reinsurance broker and consulting group, has announ...